Navigation Links
RI Hospital: Near-complete blood flow restoration critical for best outcomes in stroke
Date:10/31/2012

PROVIDENCE, R.I. Two Rhode Island Hospital researchers recently found that restoring near-complete blood flow to the brain is necessary to restore or preserve neurological function following stroke. Seems like a no-brainer, right?

Yet until their research was complete, many physicians and researchers believed that partial blood-flow restoration was good enough. Not anymore.

The study by Mahesh Jayaraman, M.D., director of interventional neuroradiology, and Brian Silver, M.D., director of the Comprehensive Stroke Center at Rhode Island Hospital, is published online in advance of print in the American Journal of Neuroradiology.

The researchers found that when performing intra-arterial stroke therapy putting a catheter directly into a blood vessel in the brain in an effort to open it it's simply not enough to open some of the vessels. Rather, opening the vast majority of the vessels is needed to truly restore neurological function in patients with acute ischemic stroke who are ineligible for, or fail to improve following intravenous tissue plasminogen activator (tPA), a common treatment for stroke.

"Stroke caused by a large blockage in the brain is potentially debilitating," Jayaraman said. "But if we can successfully restore blood flow to the majority of the blood vessels in the brain, then we may be able to help reduce the severity of a patient's stroke. While previous studies have shown that any restoration of blood flow can help, our results are the first to show that near-complete restoration is needed to help improve patient outcomes, including the preservation of fine and gross motor skills, speech and behavior."

The purpose of the study was to determine whether the degree of restoration of blood flow to the brain has an impact on the degree of brain damage and clinical outcomes. The study found that there are, in fact, significant differences in clinical outcomes between partial and near-complete blood flow restoration following intra-arterial stroke therapy for strokes that occur in the front part of the brain. As a result, Jayaraman and Silver concluded that future patient care plans should focus on restoring as much blood flow as possible, combining new technologies with a health care infrastructure designed to deliver rapid care.

"Rapid treatment is critical for stroke patients," Silver said. "It's not enough to just open blood vessels to the brain; it has to be done as early as possible. At Rhode Island Hospital, more than 50 percent of our patients are treated with intravenous clot busters (tPA) in less than 60 minutes after arrival, and a significant number of stroke patients are being treated with an intra-arterial therapy in less than two hours from the time they arrive. Stroke treatment needs to evolve, and that includes using new technologies that allow physicians to remove the clot in its entirety as quickly as possible."

Stroke is a leading cause of death in the United States; more than 800,000 people in the U.S. die each year from cardiovascular disease and strokes. Sometimes called a "brain attack," stroke occurs when a clot blocks the blood supply to the brain or when a blood vessel in the brain bursts. If not treated in a timely manner, stroke can cause death or significant disability, such as paralysis, speech difficulties and emotional problems.


'/>"/>

Contact: Ellen Slingsby
eslingsby@lifespan.org
401-444-6421
Lifespan
Source:Eurekalert

Related medicine news :

1. Inhaled Steroids Lead to Big Drop in Asthma Deaths at Texas Hospital: Study
2. Many Test Results Left Unread as Patients Leave Hospital: Study
3. Infection Might Raise Blood Clot Risk for Older Adults: Study
4. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
5. Common Blood Pressure Drug Safe for Heart Failure: Study
6. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
7. High Blood Pressure May Be Especially Lethal for Blacks
8. Changes in gene expression may help explain high blood pressure in pregnancy
9. Researchers Develop Blood Test for Depression
10. Naturopathic care can improve blood sugar, mood in diabetes
11. Diabetes Groups Issue New Guidelines on Blood Sugar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: